2024-08-02  7:31:29 PM Chg. -5.55 Volume Bid7:31:33 PM Ask7:31:33 PM Market Capitalization Dividend Y. P/E Ratio
78.85EUR -6.58% 0
Turnover: 0.00
-Bid Size: - -Ask Size: - 4.27 bill.EUR 1.64% 24.72

Business description

Laboratorios Farmaceuticos Rovi, S.A., headquartered in Madrid, Spain, develops, manufactures, and markets pharmaceutical products globally. Key products include Enoxaparin Rovi, Hibor, and Iomeron. Rovi also offers contract manufacturing services for prefilled syringes, vials, and more. Founded in 1946, it operates across cardiology, women's health, pain management, and other therapeutic areas.
 

Management board & Supervisory board

CEO
Juan López-Belmonte Encina
Management board
-
Supervisory board
Iván López-Belmonte Encina, Fátima Báñez García, Marina del Corral Téllez, Marcos Peña Pinto, Teresa Corzo Santamaría, Gabriel Núñez Fernández, Ignacio Zarzalejos Toledano, Juan López-Belmonte Encina, Javier López-Belmonte Encina
 

Company data

Name: Laboratorios Farmaceuticos Rovi, S.A.
Address: Calle José Isbert, 2,28223 Pozuelo de Alarcón (Madrid)
Phone: +34-91-021-3000
Fax: -
E-mail: rovi@rovi.es
Internet: https://www.rovi.es/
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12-31
Free Float: 35.68%
IPO date: -

Investor relations

Name: -
IR phone: +34-91-244-4422
IR Fax: -
IR e-mail: ir@rovi.es

Main Shareholders